Table 3.
End point | No of patients | HR (95% CI) | P-value | |
---|---|---|---|---|
Age (≤50 years vs >50 years) | 47 | 47 | 1.344 (0.7618–2.453) | 0.3083 |
EphB4 expression (low vs high) | 48 | 46 | 1.462 (0.8339–2.707) | 0.1880 |
EphrinB2 expression (low vs high) | 47 | 47 | 1.697 (0.9814–3.180) | 0.0666 |
Metastatic axillary nodes (≤3 vs >3) | 68 | 26 | 1.494 (0.8122–3.127) | 0.1880 |
Diameter of primary tumor (≤20 mm vs >20 mm) | 5 | 89 | 0.385 (0.1427–1.824) | 0.3138 |
Histologic grade (1/2 vs 3) | 74 | 20 | 1.338 (0.6692–2.927) | 0.3857 |
TNM staging (I/II vs III/IV) | 57 | 37 | 1.897 (1.1180–3.854) | 0.0247 |
Abbreviations: HR, hazard ratio; CI, confidence interval; TNM, tumor–node–metastasis.